Evidence map›Paper›PMID 40551959›Full record

ReviewJournal of hepatocellular carcinoma2025

Application of Robotic Surgery in Hepatocellular Carcinoma.

Pei-Heng Li, Zhao-Wei Ding, Yong-Qing Ye

Abstract readReview
In one paragraph

Review in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pei-Heng LiDepartment of Oncology, Foshan Nanhai District Fifth People's Hospital, Foshan, Guangdong Province, 528000, People's Republic of China.
Zhao-Wei DingDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, 510120, People's Republic of China.
Yong-Qing YeDepartment of Hepatobiliary Surgery, The Second People's Hospital of Foshan, Foshan, Guangdong Province, 528000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) has a lot of possible treatment strategies. At present, the clinical treatment of Hepatocellular carcinoma is mainly surgical treatment, according to the different conditions of patients, there are also differences in the choice of surgical methods. Open liver resection, laparoscopic liver resection, and robotic liver resection are some of the suitable treatment options. In this paper, the current advantages, limitations, and future of robotic surgery in HCC are reviewed and analyzed for clinicians' reference.

Indexed as

Hepatocellular carcinomarobotic liver resectionsurgery

Identifiers

PMID40551959
PMCPMC12184679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.